EMA: Questions and answers on the European Medicines Agency policy on publication of clinical data for medicinal products for human use

The European Medicines Agency (EMA) has committed to continuously extending its approach to transparency. A key goal in this process is the proactive publication of clinical-trial data for medicines once the decision-making process on an application for a European Union (EU)-wide marketing authorisation is complete.